Machine learning-based modeling to predict inhibitors for targets of Alzheimer's Disease

Alzheimer’s Disease is a chronic neurodegenerative disorder projected to affect 115 million people by 2050, driven by mechanisms like the cholinergic and amyloid hypotheses and insulin signaling disruptions involving key targets such as BACE-1, AChE, and GSK-3 beta. Utilizing machine learning (ML), …

View Post on Scour ↗

More from arXiv on Scour.